Kodikaz Therapeutic Solutions
Lei Feng is currently the Associate Director at Kodikaz Therapeutic Solutions, Inc, with previous experience as a Senior Scientist at MeiraGTx. Lei created a platform for high throughput screening libraries in mammalian cells and identified riboswitches that are significantly more effective than previous reports. With a background in post-doctoral research at Albert Einstein College of Medicine, Lei developed and optimized a technique for in situ fucosylation, both in vitro and in vivo. Lei also holds a Ph.D. in MCB from the University of Washington.
This person is not in any offices
Kodikaz Therapeutic Solutions
The Kodikaz goal is to move from incremental cancer therapies with devastating side effects to durable cures through targeted therapies that can eradicate cancers completely.